Impact News +++ Steppe Gold doubles ATO mine resource (Mining.com) +++ STEPPE GOLD Aktie +5,70%

CELSION Aktie

 >CELSION Aktienkurs 
1.96 EUR    +3.1%    (Tradegate)
Ask: 2.02 EUR / 3000 Stück
Bid: 1.98 EUR / 3100 Stück
Tagesumsatz: 37317 Stück
Realtime Kurs von 8 bis 22 Uhr!
>CELSION Performance
1 Woche: +7,7%
1 Monat: +74,3%
3 Monate: +351,8%
6 Monate: +118,3%
1 Jahr: +55,7%
laufendes Jahr: +238,2%
>CELSION Aktie
Name:  CELSION CORP. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US15117N5032 / A2DQRG
Symbol/ Ticker:  CBOC (Frankfurt) / CLSN (NASDAQ)
Kürzel:  FRA:CBOC, CBOC.F, CBOC:GR, NASDAQ:CLSN
Index:  -
Webseite:  http://celsion.com/
Marktkapitalisierung:  180.82 Mio. EUR
Umsatz:  0.41 Mio. EUR
EBITDA:  -14.53 Mio. EUR
Gewinn je Aktie:  -0.614 EUR
Schulden:  5.17 Mio. EUR
Liquide Mittel:  15.07 Mio. EUR
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -4.22
KUV/ KBV/ PEG:  361.64 / 4.69 / -
Gewinnm./ Eigenkapitalr.:  - / -126.47%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  CELSION, CELSION S, CELSION'S
Letzte Datenerhebung:  23.02.21
>CELSION Eigentümer
Aktien: 73.23 Mio. St.
f.h. Aktien: 30.5 Mio. St.
Insider Eigner: 1.25%
Instit. Eigner: 17.99%
Leerverk. Aktien: 3.16%
>CELSION Peer Group

 
24.02.21 - 10:57
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:54
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:48
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:45
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:42
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:39
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:36
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:30
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:27
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:24
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:21
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:18
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:15
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:12
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:06
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 10:00
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 09:57
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 09:54
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 09:51
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
24.02.21 - 09:48
BCLI Slips On FDA Feedback, OTIC Plunges As Ménière′s Disease Trial Fails, CLNN On Watch (RTTNews)
 
Today's Daily Dose brings you news about disappointing results from Otonomy's phase III trial of OTIVIDEX in Ménière's disease, FDA'S feedback related to BrainStorm's NurOwn cell therapy, Fast Track designation for Celsion's ovarian cancer dr...
>Zitat des Tages: Es ist nötig, alle seine Kenntnisse umzurühren und sie dann wieder setzen zu lassen, um zu sehen, wie sich alles setzt. - Georg Christoph Lichtenberg
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!